Expression of TGF-β/Smad pathway-related indices in patients with isolated iliac artery aneurysms complicated with iliac arteriovenous fistula and their relationship with prognosis.
Isolated iliac artery aneurysms
TGF/Smad pathway phase
iliac arteriovenous fistula
prognosis
Journal
Clinical and experimental hypertension (New York, N.Y. : 1993)
ISSN: 1525-6006
Titre abrégé: Clin Exp Hypertens
Pays: England
ID NLM: 9305929
Informations de publication
Date de publication:
31 Dec 2024
31 Dec 2024
Historique:
medline:
30
7
2024
pubmed:
30
7
2024
entrez:
30
7
2024
Statut:
ppublish
Résumé
This study investigated the expression of TGF-β/Smad pathway-related indices in patients with isolated iliac artery aneurysms (IIAA) complicated with iliac arteriovenous fistula (IAVF) and their relationship with prognosis. From January 2016 to June 2022, 83 patients with IIAA complicated with IAVF (Study group) and 54 patients with IIAA not complicated with IAVF (control group) were studied. The related indices of TGF-β/Smad pathway were evaluated, and the effects of each index on the formation of IAVF were analyzed. The patients were divided into the survival group (64 cases) and death group (19 cases), and the prognostic value of indices in combination was analyzed. TGF-β, p-Smad2, p-Smad3, p-JNK, and p-ERK in the study group were higher than those in the control group. Abnormal increase of pSmad3 expression was a risk factor for IAVF formation in patients with IIAA. TGF-β level in the death group was higher than that in the survival group, and p-Smad3 and p-JNK proteins were higher than those in the survival group. The AUC value of indices in the TGF-β/Smad pathway in combination was greater than that of each index alone. Abnormal increased expression of pSmad3 was a risk factor for prognosis of patients with IIAA complicated with IAVF. The abnormal increase of TGF-β/Smad pathway-related indices is related to poor prognosis of patients with IIAA complicated with IAVF, and the combined detection of all indices has a predictive value for patients' prognosis.
Identifiants
pubmed: 39077772
doi: 10.1080/10641963.2024.2380291
doi:
Substances chimiques
Transforming Growth Factor beta
0
Smad3 Protein
0
SMAD3 protein, human
0
SMAD2 protein, human
0
Smad Proteins
0
Smad2 Protein
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM